XT
BMGL

XTX Topco’s Basel Medical BMGL Stock Holding History

XTX Topco’s Portfolio BMGL Stock Details BMGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.7K Sell
2,146
-390
-15% -$3.08K ﹤0.01% 3607
2025
Q4 		$14.9K Buy
+2,536
New +$37.4K ﹤0.01% 3122

Other funds holding BMGL

TC
T3 Companies New York $76.8M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's BMGL Position: Q1 2026 in Review

XTX Topco reduced its Basel Medical (BMGL) stake by 15% in Q1 2026, selling an estimated $3.08K and leaving 2,146 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.

XTX Topco first reported a position in BMGL in Q4 2025 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold BMGL as of Q1 2026.

  • XTX Topco held 2,146 shares of Basel Medical worth $15.7K as of Q1 2026.
  • XTX Topco sold 390 Basel Medical shares in Q1 2026, an estimated $3.08K.
  • Basel Medical made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3607 holding.
  • XTX Topco first reported a position in Basel Medical in Q4 2025 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Basel Medical as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.